Product Code: PM2812
The global human microbiome market size is expected to reach USD 1,276.3 million by 2030, according to a new study by Polaris Market Research. The report "Human Microbiome Market Share, Size, Trends, Industry Analysis Report, By Product (Probiotics, Prebiotics, Medical Foods, Supplements, and Others); By Application; By Disease, By Type; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
With so many small high-tech firms functioning in the industry, there are numerous high-growth prospects for important stakeholders to purchase out corporations in order to investigate microbiomes with the goal of uncovering novel medications and therapeutic targets for various indications such as obesity, diabetes, liver problems, and metabolic diseases. Many industry leaders are working on strategic alliances and partnerships to expand their product pipelines through well-organized R&D approaches.
Several alliances and partnerships involving large corporations have occurred in the recent two years. The FDA has not authorized any probiotics as a live biotechnology-derived product. However, there are U.S. food and drug administration foods, including nutritional supplements, incorporating microorganisms that are legitimately accessible. Still, these items cannot be legally advertised to reduce or avoid illness.
The federal government's increased investment is expected to support market expansion. Furthermore, the high return on investment ensured by research efforts would benefit the industry. Contrarily, high costs associated with R&D capabilities, limited infrastructure, and insufficient research on the human microbiome are projected to stymie market expansion. In addition, a lack of favorable economic scenarios and technological penetration in emerging economies, obstacles to proving the causal connection between dysbiosis and illnesses, and a lack of suitable infrastructure in low & middle-income countries are expected to pose challenges to the market for the foreseeable future.
Human Microbiome Market Report Highlights
North America will be the dominating region in the global market in 2021. The region's dominance is attributed to factors such as the presence of well-established players and advancements in the R&D toward gut microbiome.
By application, the therapeutics segment dominated the global market owing to increased funding for R&D into microbiome-based therapies across developing nations such as India and developed nations such as the US.
By disease, infectious diseases account for the largest share owing to weak immune systems and less availability of nutritional diets across developing countries such as Africa, China, and India.
By Product, the probiotic segment is the largest and fastest-growing segment owing to growing awareness among consumers for healthy and natural foods. Furthermore, the pandemic had a favorable impact on sales in this segment.
Key players in the global market include Rebiotix., Metabiomics, Yakult Honsha, Osel Inc., Vedanta Biosciences, Synthetic Biologics, and DuPont.
Polaris Market Research has segmented the human microbiome market report based on type, application, disease, product, and region:
Human Microbiome, Product Outlook (Revenue - USD Million, 2018 - 2030)
Probiotics
Prebiotics
Medical Foods
Supplements
Others
Human Microbiome, Disease Outlook (Revenue - USD Million, 2018 - 2030)
Infectious
Endocrine
Metabolic
Human Microbiome, Application Outlook (Revenue - USD Million, 2018 - 2030)
Therapeutics
Diagnostics
Human Microbiome, Type Outlook (Revenue - USD Million, 2018 - 2030)
FMT
Peptide
Live Biotherapeutic Product
Others
Human Microbiome, Regional Outlook (Revenue - USD Million, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Human Microbiome Market Insights
- 4.1. Human Microbiome - Industry Snapshot
- 4.2. Human Microbiome Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing collaboration between public-private organizations
- 4.2.1.2. Growing research activity in medical drug discovery
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Government regulations
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Human Microbiome Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Human Microbiome Market, by Application
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 5.3. Therapeutics
- 5.3.1. Global Human Microbiome Market, by Therapeutics, by Region, 2018 - 2030 (USD Million)
- 5.4. Diagnostics
- 5.4.1. Global Human Microbiome Market, by Diagnostics, by Region, 2018 - 2030 (USD Million)
6. Global Human Microbiome Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 6.3. Probiotics
- 6.3.1. Global Human Microbiome Market, by Probiotics, by Region, 2018 - 2030 (USD Million)
- 6.4. Prebiotics
- 6.4.1. Global Human Microbiome Market, by Prebiotics, by Region, 2018 - 2030 (USD Million)
- 6.5. Medical Foods
- 6.5.1. Global Human Microbiome Market, by Medical Foods, by Region, 2018 - 2030 (USD Million)
- 6.6. Supplements
- 6.6.1. Global Human Microbiome Market, by Supplements, by Region, 2018 - 2030 (USD Million)
- 6.7. Others
- 6.7.1. Global Human Microbiome Market, by Others, by Region, 2018 - 2030 (USD Million)
7. Global Human Microbiome Market, by Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 7.3. FMT
- 7.3.1. Global Human Microbiome Market, by FMT, by Region, 2018 - 2030 (USD Million)
- 7.4. Peptide
- 7.4.1. Global Human Microbiome Market, by Peptide, by Region, 2018 - 2030 (USD Million)
- 7.5. Live Biotherapeutic Product
- 7.5.1. Global Human Microbiome Market, by Live Biotherapeutic Product, by Region, 2018 - 2030 (USD Million)
- 7.6. Others
- 7.6.1. Global Other Human Microbiome Market, by Region, 2018 - 2030 (USD Million)
8. Global Human Microbiome Market, by Disease
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 8.3. Infectious
- 8.3.1. Global Human Microbiome Market, by Infectious, by Region, 2018 - 2030 (USD Million)
- 8.4. Endocrine
- 8.4.1. Global Human Microbiome Market, by Endocrine, by Region, 2018 - 2030 (USD Million)
- 8.5. Metabolic
- 8.5.1. Global Human Microbiome Market, by Metabolic, by Region, 2018 - 2030 (USD Million)
9. Global Human Microbiome Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Human Microbiome Market Assessment, By Geography, 2018 - 2030 (USD Million)
- 9.3. Human Microbiome Market - North America
- 9.3.1. North America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.3.2. North America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.3.3. North America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.3.4. North America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.3.5. Human Microbiome Market - U.S.
- 9.3.5.1. U.S.: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.3.5.2. U.S.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.3.5.3. U.S.: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.3.5.4. U.S.: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.3.6. Human Microbiome Market - Canada
- 9.3.6.1. Canada: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.3.6.2. Canada: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.3.6.3. Canada: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.3.6.4. Canada: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4. Human Microbiome Market - Europe
- 9.4.1. Europe: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.2. Europe: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.3. Europe: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.4. Europe: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.5. Human Microbiome Market - UK
- 9.4.5.1. UK: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.5.2. UK: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.5.3. UK: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.5.4. UK: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.6. Human Microbiome Market - France
- 9.4.6.1. France: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.6.2. France: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.6.3. France: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.6.4. France: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.7. Human Microbiome Market - Germany
- 9.4.7.1. Germany: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.7.2. Germany: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.7.3. Germany: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.7.4. Germany: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.8. Human Microbiome Market - Italy
- 9.4.8.1. Italy: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.8.2. Italy: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.8.3. Italy: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.8.4. Italy: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.9. Human Microbiome Market - Spain
- 9.4.9.1. Spain: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.9.2. Spain: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.9.3. Spain: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.9.4. Spain: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.10. Human Microbiome Market - Netherlands
- 9.4.10.1. Netherlands: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.10.2. Netherlands: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.10.3. Netherlands: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.10.4. Netherlands: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.4.11. Human Microbiome Market - Russia
- 9.4.11.1. Russia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.4.11.2. Russia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.4.11.3. Russia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.4.11.4. Russia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5. Human Microbiome Market - Asia Pacific
- 9.5.1. Asia Pacific: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.2. Asia Pacific: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.3. Asia Pacific: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.4. Asia Pacific: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.5. Human Microbiome Market - China
- 9.5.5.1. China: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.5.2. China.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.5.3. China: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.5.4. China: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.6. Human Microbiome Market - India
- 9.5.6.1. India: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.6.2. India.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.6.3. India: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.6.4. India: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.7. Human Microbiome Market - Japan
- 9.5.7.1. Japan: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.7.2. Japan.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.7.3. Japan: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.7.4. Japan: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.8. Human Microbiome Market - Malaysia
- 9.5.8.1. Malaysia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.8.2. Malaysia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.8.3. Malaysia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.8.4. Malaysia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.9. Human Microbiome Market - Indonesia
- 9.5.9.1. Indonesia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.9.2. Indonesia.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.9.3. Indonesia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.9.4. Indonesia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.5.10. Human Microbiome Market - South Korea
- 9.5.10.1. South Korea: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.5.10.2. South Korea.: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.5.10.3. South Korea: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.5.10.4. South Korea: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.6. Human Microbiome Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.6.2. Middle East & Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.6.3. Middle East & Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.6.4. Middle East & Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.6.5. Human Microbiome Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.6.5.2. Saudi Arabia: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.6.5.3. Saudi Arabia: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.6.5.4. Saudi Arabia: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.6.6. Human Microbiome Market - South Africa
- 9.6.6.1. South Africa: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.6.6.2. South Africa: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.6.6.3. South Africa: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.6.6.4. South Africa: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.6.7. Human Microbiome Market - Israel
- 9.6.7.1. Israel: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.6.7.2. Israel: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.6.7.3. Israel: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.6.7.4. Israel: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.6.8. Human Microbiome Market - UAE
- 9.6.8.1. UAE: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.6.8.2. UAE: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.6.8.3. UAE: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.6.8.4. UAE: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.7. Human Microbiome Market - Latin America
- 9.7.1. Latin America: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.7.2. Latin America: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.7.3. Latin America: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.7.4. Latin America: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.7.5. Human Microbiome Market - Mexico
- 9.7.5.1. Mexico: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.7.5.2. Mexico: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.7.5.3. Mexico: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.7.5.4. Mexico: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.7.6. Human Microbiome Market - Brazil
- 9.7.6.1. Brazil: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.7.6.2. Brazil: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.7.6.3. Brazil: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.7.6.4. Brazil: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
- 9.7.7. Human Microbiome Market - Argentina
- 9.7.7.1. Argentina: Human Microbiome Market, by Application, 2018 - 2030 (USD Million)
- 9.7.7.2. Argentina: Human Microbiome Market, by Disease, 2018 - 2030 (USD Million)
- 9.7.7.3. Argentina: Human Microbiome Market, by Product, 2018 - 2030 (USD Million)
- 9.7.7.4. Argentina: Human Microbiome Market, by Type, 2018 - 2030 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Rebiotix
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Metabiomics Corporate
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Yakult Honsha
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Osel Inc
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Vedanta Biosciences, Inc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Synthetic Biologics
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. DuPont
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development